Тёмный

Professor Derek Mann - Liver Cancer Immunotherapy 

LIVErNORTH
Подписаться 407
Просмотров 128
50% 1

A talk plus Q&A session delivered to LIVErNORTH members via Zoom on 3rd October 2023. Some innovative and very promising treatments for liver cancer on trial with some early positive results. Some good, relevant questions from the audience followed. Prof Mann is the head of the Newcastle Fibrosis Research Group (NFRG). His main research interests are the transcriptional control of inflammation, epigenetic control of fibrosis and the role of age-related chronic inflammation in ageing and cancer.

Опубликовано:

 

3 окт 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 2   
@khaliddurrani6432
@khaliddurrani6432 5 месяцев назад
Systemic therapy with ICI and TKI ( At+ Bev ) can also be combined with liver directed therapies for down staging as well as a bridge to liver resection or transplantation.
@khaliddurrani6432
@khaliddurrani6432 5 месяцев назад
For any comprehensive overview of HCC an HPB surgeon would be necessary to elaborate on the only curative treatment of such a morbid disease.
Далее
Update on Autoimmune Liver Disease - Dr Jess Dyson
52:41
Your bathroom needs this
00:58
Просмотров 11 млн
Prof David Jones PBC 'Is the fog beginning to clear'
1:14:10
PBC, the Vaccine and immunosupressed patients.
1:35:09